About the Autoimmune Ocular Disease and Allergy Session
Autoimmune ocular diseases, such as uveitis and scleritis, occur when the immune system erroneously targets eye tissues, resulting in inflammation and potential vision impairment. These conditions often accompany systemic autoimmune disorders like rheumatoid arthritis and lupus. In contrast, allergic eye diseases, such as allergic conjunctivitis, are triggered by an overreaction of the immune system to allergens like pollen or pet dander, leading to symptoms like itching, redness, and tearing. While both autoimmune and allergic ocular conditions involve inflammatory processes, their triggers and immune responses differ. Effective management requires identifying the cause, utilizing anti-inflammatory medications, and avoiding allergens. Prompt diagnosis and treatment are essential for preserving vision and enhancing quality of life.
Topics Covered in Autoimmune Ocular Disease and Allergy
Autoimmune Uveitis
Scleritis
Rheumatoid Arthritis & Lupus
Allergic Conjunctivitis
Vernal & Atopic Keratoconjunctivitis
Topical Antihistamines
Related Scientific Sessions at IOC 2027
Why Attend the Autoimmune Ocular Disease and Allergy Conference 2027
Earn CPD Credit
Sessions are CPD-accredited by The CPD Group (UK) — one CPD credit for every hour of attendance.
Present Your Research
Oral and poster slots for original Autoimmune Ocular Disease and Allergy work, reviewed by the scientific committee.
Network Globally
Meet ophthalmologists, vision scientists, and eye-care clinicians from around the world across three days.
Publish & Get Indexed
Accepted abstracts are compiled into the conference proceedings and indexed in Scopus and Web of Science.
Learn from Keynotes
Plenary lectures from leading voices shaping Autoimmune Ocular Disease and Allergy research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join IOC 2027 for the Autoimmune Ocular Disease and Allergy track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Autoimmune Ocular Disease and Allergy Conference 2027 — FAQs
What is the Autoimmune Ocular Disease and Allergy track at IOC 2027?
The Autoimmune Ocular Disease and Allergy track is a dedicated stream within IOC 2027 covering the latest research, clinical innovation, and best practice in Autoimmune Ocular Disease and Allergy. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Autoimmune Ocular Disease and Allergy sessions?
Ophthalmologists, optometrists, vision scientists, educators, doctoral students, and trainees with an interest in Autoimmune Ocular Disease and Allergy are all welcome — whether presenting or attending.
Can I present my research in the Autoimmune Ocular Disease and Allergy track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Autoimmune Ocular Disease and Allergy sessions?
Yes. IOC 2027 is a hybrid conference — attend the Autoimmune Ocular Disease and Allergy track in person in Singapore or join live online, with on-demand access afterward.
Join the IOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.